GO:0005829 | cytosol | 7.97e-07 | 1.15e-02 | 2.531 | 8 | 132 | 2496 |
GO:0019083 | viral transcription | 9.36e-06 | 1.35e-01 | 6.061 | 3 | 10 | 81 |
GO:0006415 | translational termination | 1.16e-05 | 1.68e-01 | 5.958 | 3 | 10 | 87 |
GO:0006414 | translational elongation | 1.42e-05 | 2.05e-01 | 5.862 | 3 | 13 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.99e-05 | 2.87e-01 | 5.701 | 3 | 10 | 104 |
GO:0042273 | ribosomal large subunit biogenesis | 2.09e-05 | 3.02e-01 | 8.116 | 2 | 4 | 13 |
GO:0070062 | extracellular vesicular exosome | 2.40e-05 | 3.46e-01 | 2.395 | 7 | 104 | 2400 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.62e-05 | 3.77e-01 | 5.568 | 3 | 11 | 114 |
GO:0019058 | viral life cycle | 2.69e-05 | 3.87e-01 | 5.556 | 3 | 13 | 115 |
GO:0006413 | translational initiation | 3.97e-05 | 5.72e-01 | 5.368 | 3 | 17 | 131 |
GO:0003735 | structural constituent of ribosome | 4.53e-05 | 6.54e-01 | 5.303 | 3 | 10 | 137 |
GO:0044267 | cellular protein metabolic process | 7.26e-05 | 1.00e+00 | 3.927 | 4 | 29 | 474 |
GO:0016032 | viral process | 1.15e-04 | 1.00e+00 | 3.755 | 4 | 55 | 534 |
GO:0016071 | mRNA metabolic process | 1.93e-04 | 1.00e+00 | 4.600 | 3 | 31 | 223 |
GO:0006412 | translation | 2.11e-04 | 1.00e+00 | 4.556 | 3 | 20 | 230 |
GO:0016070 | RNA metabolic process | 2.61e-04 | 1.00e+00 | 4.453 | 3 | 32 | 247 |
GO:0022625 | cytosolic large ribosomal subunit | 3.12e-04 | 1.00e+00 | 6.201 | 2 | 6 | 49 |
GO:0004151 | dihydroorotase activity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0016020 | membrane | 8.83e-04 | 1.00e+00 | 2.423 | 5 | 90 | 1681 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0006364 | rRNA processing | 1.15e-03 | 1.00e+00 | 5.261 | 2 | 6 | 94 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0006543 | glutamine catabolic process | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0051414 | response to cortisol | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 3 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 2 | 5 |
GO:0030957 | Tat protein binding | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 3 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0033180 | proton-transporting V-type ATPase, V1 domain | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 2 | 7 |
GO:0000028 | ribosomal small subunit assembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 2 | 7 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 2 | 8 |
GO:0070688 | MLL5-L complex | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0045116 | protein neddylation | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 2 | 8 |
GO:0010467 | gene expression | 4.67e-03 | 1.00e+00 | 3.015 | 3 | 59 | 669 |
GO:0006228 | UTP biosynthetic process | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0014075 | response to amine | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0031000 | response to caffeine | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 2 | 9 |
GO:0035267 | NuA4 histone acetyltransferase complex | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 4 | 14 |
GO:0004180 | carboxypeptidase activity | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 14 |
GO:0046961 | proton-transporting ATPase activity, rotational mechanism | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 3 | 15 |
GO:0046034 | ATP metabolic process | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 15 |
GO:0050998 | nitric-oxide synthase binding | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0006541 | glutamine metabolic process | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 17 |
GO:0017144 | drug metabolic process | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 18 |
GO:0015078 | hydrogen ion transmembrane transporter activity | 1.05e-02 | 1.00e+00 | 6.568 | 1 | 3 | 19 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.05e-02 | 1.00e+00 | 6.568 | 1 | 1 | 19 |
GO:0043234 | protein complex | 1.08e-02 | 1.00e+00 | 3.612 | 2 | 18 | 295 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 21 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 22 |
GO:0033574 | response to testosterone | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 22 |
GO:0030863 | cortical cytoskeleton | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 4 | 23 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 3 | 23 |
GO:0043236 | laminin binding | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0004177 | aminopeptidase activity | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0003723 | RNA binding | 1.43e-02 | 1.00e+00 | 3.398 | 2 | 20 | 342 |
GO:0015991 | ATP hydrolysis coupled proton transport | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 4 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 3 | 26 |
GO:0019843 | rRNA binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 3 | 27 |
GO:0043022 | ribosome binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 3 | 27 |
GO:0031492 | nucleosomal DNA binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 4 | 27 |
GO:0019894 | kinesin binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 28 |
GO:0034504 | protein localization to nucleus | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 2 | 28 |
GO:0019005 | SCF ubiquitin ligase complex | 1.60e-02 | 1.00e+00 | 5.958 | 1 | 1 | 29 |
GO:0015992 | proton transport | 1.60e-02 | 1.00e+00 | 5.958 | 1 | 3 | 29 |
GO:0033572 | transferrin transport | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 5 | 30 |
GO:0044822 | poly(A) RNA binding | 1.66e-02 | 1.00e+00 | 2.357 | 3 | 49 | 1056 |
GO:0051701 | interaction with host | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 4 | 32 |
GO:0001895 | retina homeostasis | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 34 |
GO:0006605 | protein targeting | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 2 | 35 |
GO:0034332 | adherens junction organization | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 36 |
GO:0090382 | phagosome maturation | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 5 | 36 |
GO:0008234 | cysteine-type peptidase activity | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 3 | 37 |
GO:0018107 | peptidyl-threonine phosphorylation | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 4 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 4 | 37 |
GO:0005902 | microvillus | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 2 | 38 |
GO:0070527 | platelet aggregation | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 2 | 38 |
GO:0022627 | cytosolic small ribosomal subunit | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 4 | 39 |
GO:0007595 | lactation | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 2 | 39 |
GO:0043195 | terminal bouton | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 1 | 41 |
GO:0021762 | substantia nigra development | 2.42e-02 | 1.00e+00 | 5.357 | 1 | 2 | 44 |
GO:0035690 | cellular response to drug | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 2 | 49 |
GO:0004197 | cysteine-type endopeptidase activity | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 3 | 50 |
GO:0031100 | organ regeneration | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 4 | 50 |
GO:0006879 | cellular iron ion homeostasis | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 4 | 51 |
GO:0005524 | ATP binding | 2.88e-02 | 1.00e+00 | 2.059 | 3 | 60 | 1298 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 5 | 53 |
GO:0045216 | cell-cell junction organization | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 54 |
GO:0012505 | endomembrane system | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 2 | 56 |
GO:0042995 | cell projection | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 6 | 60 |
GO:0009636 | response to toxic substance | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 3 | 65 |
GO:0034329 | cell junction assembly | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 1 | 68 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 2 | 70 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 6 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.09e-02 | 1.00e+00 | 4.587 | 1 | 2 | 75 |
GO:0001889 | liver development | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 4 | 77 |
GO:0007565 | female pregnancy | 4.25e-02 | 1.00e+00 | 4.531 | 1 | 1 | 78 |
GO:0001726 | ruffle | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 4 | 80 |
GO:0042470 | melanosome | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 9 | 91 |
GO:0016363 | nuclear matrix | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 12 | 91 |
GO:0006928 | cellular component movement | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 8 | 91 |
GO:0071456 | cellular response to hypoxia | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 6 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 21 | 92 |
GO:0014069 | postsynaptic density | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 3 | 105 |
GO:0072562 | blood microparticle | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 8 | 112 |
GO:0005515 | protein binding | 6.16e-02 | 1.00e+00 | 0.845 | 6 | 184 | 6024 |
GO:0000209 | protein polyubiquitination | 6.26e-02 | 1.00e+00 | 3.958 | 1 | 20 | 116 |
GO:0006325 | chromatin organization | 6.36e-02 | 1.00e+00 | 3.933 | 1 | 5 | 118 |
GO:0007219 | Notch signaling pathway | 6.47e-02 | 1.00e+00 | 3.909 | 1 | 5 | 120 |
GO:0000790 | nuclear chromatin | 6.94e-02 | 1.00e+00 | 3.805 | 1 | 9 | 129 |
GO:0007507 | heart development | 7.46e-02 | 1.00e+00 | 3.697 | 1 | 7 | 139 |
GO:0008286 | insulin receptor signaling pathway | 7.61e-02 | 1.00e+00 | 3.666 | 1 | 7 | 142 |
GO:0006457 | protein folding | 7.66e-02 | 1.00e+00 | 3.656 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 7.77e-02 | 1.00e+00 | 3.636 | 1 | 7 | 145 |
GO:0046777 | protein autophosphorylation | 8.44e-02 | 1.00e+00 | 3.512 | 1 | 7 | 158 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 8.80e-02 | 1.00e+00 | 3.450 | 1 | 7 | 165 |
GO:0030424 | axon | 8.85e-02 | 1.00e+00 | 3.441 | 1 | 4 | 166 |
GO:0004672 | protein kinase activity | 9.41e-02 | 1.00e+00 | 3.348 | 1 | 6 | 177 |
GO:0031625 | ubiquitin protein ligase binding | 9.46e-02 | 1.00e+00 | 3.340 | 1 | 14 | 178 |
GO:0032403 | protein complex binding | 9.71e-02 | 1.00e+00 | 3.300 | 1 | 10 | 183 |
GO:0008270 | zinc ion binding | 1.01e-01 | 1.00e+00 | 1.855 | 2 | 12 | 997 |
GO:0005765 | lysosomal membrane | 1.07e-01 | 1.00e+00 | 3.151 | 1 | 5 | 203 |
GO:0005654 | nucleoplasm | 1.16e-01 | 1.00e+00 | 1.737 | 2 | 76 | 1082 |
GO:0043025 | neuronal cell body | 1.28e-01 | 1.00e+00 | 2.879 | 1 | 9 | 245 |
GO:0005737 | cytoplasm | 1.30e-01 | 1.00e+00 | 0.937 | 4 | 110 | 3767 |
GO:0004842 | ubiquitin-protein transferase activity | 1.33e-01 | 1.00e+00 | 2.822 | 1 | 6 | 255 |
GO:0006281 | DNA repair | 1.36e-01 | 1.00e+00 | 2.788 | 1 | 18 | 261 |
GO:0019899 | enzyme binding | 1.44e-01 | 1.00e+00 | 2.702 | 1 | 12 | 277 |
GO:0042493 | response to drug | 1.47e-01 | 1.00e+00 | 2.666 | 1 | 13 | 284 |
GO:0005856 | cytoskeleton | 1.50e-01 | 1.00e+00 | 2.631 | 1 | 12 | 291 |
GO:0016567 | protein ubiquitination | 1.52e-01 | 1.00e+00 | 2.612 | 1 | 5 | 295 |
GO:0019901 | protein kinase binding | 1.63e-01 | 1.00e+00 | 2.508 | 1 | 21 | 317 |
GO:0043231 | intracellular membrane-bounded organelle | 1.63e-01 | 1.00e+00 | 2.503 | 1 | 9 | 318 |
GO:0007411 | axon guidance | 1.64e-01 | 1.00e+00 | 2.499 | 1 | 13 | 319 |
GO:0005925 | focal adhesion | 1.86e-01 | 1.00e+00 | 2.300 | 1 | 19 | 366 |
GO:0007155 | cell adhesion | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 6 | 369 |
GO:0006508 | proteolysis | 1.91e-01 | 1.00e+00 | 2.254 | 1 | 9 | 378 |
GO:0055085 | transmembrane transport | 2.17e-01 | 1.00e+00 | 2.051 | 1 | 10 | 435 |
GO:0007596 | blood coagulation | 2.26e-01 | 1.00e+00 | 1.986 | 1 | 18 | 455 |
GO:0042802 | identical protein binding | 2.39e-01 | 1.00e+00 | 1.897 | 1 | 20 | 484 |
GO:0045087 | innate immune response | 2.87e-01 | 1.00e+00 | 1.597 | 1 | 24 | 596 |
GO:0005615 | extracellular space | 4.23e-01 | 1.00e+00 | 0.914 | 1 | 17 | 957 |
GO:0005886 | plasma membrane | 4.34e-01 | 1.00e+00 | 0.482 | 2 | 45 | 2582 |
GO:0005634 | nucleus | 4.89e-01 | 1.00e+00 | 0.247 | 3 | 136 | 4559 |
GO:0044281 | small molecule metabolic process | 5.04e-01 | 1.00e+00 | 0.574 | 1 | 58 | 1211 |
GO:0005730 | nucleolus | 6.20e-01 | 1.00e+00 | 0.136 | 1 | 69 | 1641 |
GO:0016021 | integral component of membrane | 6.94e-01 | 1.00e+00 | -0.137 | 1 | 27 | 1982 |